Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III study

M. Z. Gilcrease

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)337-338
Number of pages2
JournalBreast Diseases
Volume21
Issue number4
DOIs
StatePublished - 2010

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this